glp-2 vs glp-1 Independent Nurse - and GIP/GLP-1 receptor agonists for type 2 diabetes GLP-1-based therapies for type 2

doi: 10.3233/RNN-130316

The current fervor for GLP-1RAs in the capital markets as well as in the general public, especially in terms of weight reduction, is probably going to result in overuse, said Chun-Su Yuan, MD, PhD, the Cyrus Tang Professor of Anesthesia and Critical Care at the University of Chicago

What types of injections are available

Future directions to overcome these challenges include biomarker-driven clinical trials that enrich enrollment with patients exhibiting high mtDAMPs or immune dysfunction, such as testing NLRP3 inhibitors in cardiac surgery patients with elevated preoperative neutrophilplatelet aggregates or high mtDNA levels after CPB, thereby increasing the power to detect benefits in those most likely to respond